Trial Profile

A Phase IIa, Placebo Controlled, Multicenter Pilot Study to Evaluate the Safety and Efficacy of BIO-11006 Inhalation Solution in Patients With Acute Respiratory Distress Syndrome

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 12 Jul 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs BIO-11006 (Primary)
Indications Adult respiratory distress syndrome
Focus Adverse reactions; Proof of concept
Sponsors BioMarck Pharmaceuticals

Most Recent Events

07 Jul 2021 According to an BioMarck Pharmaceuticals media release, data from this trial will be presented at the 2021 ARDS Drug Development Summit.
19 May 2021 Results presented at the 117th International Conference of the American Thoracic Society
12 May 2021 According to an BioMarck Pharmaceuticals media release, data from this trial will be presented at the 2021 ATS (American Thoracic Society) Annual Meeting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com